Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,186.00
Bid: 2,184.00
Ask: 2,186.00
Change: -7.00 (-0.32%)
Spread: 2.00 (0.09%)
Open: 2,195.00
High: 2,201.00
Low: 2,182.00
Yest. Close: 2,193.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Thursday broker round-up UPDATE

Aggreko: RBC Capital reduces target price from 1850p to 1680p, while its neutral rating remains unchanged. Aviva: JP Morgan raises target price from 393p to 436p and retains an overweight rating. BHP Billiton: Canaccord Genuity takes target price from 1950p to 2050p maintaining a hold recommendati

22 Aug 13 07:25

FTSE 250 movers: N Brown jumps after broker upgrade

Internet shopping group N Brown was a high riser today after Credit Suisse raised its rating for the stock from 'neutral' to 'outperform' and lifted its target price from 455p to 620p. N Brown, whose brands include Simply Be, Jacamo and Figleaves, has seen its stock surge by around 50% so far this

21 Aug 13 14:36

London midday: Ex-div stocks drag FTSE 100 to six-week low

Markets were sharply lower on Wednesday morning as risk appetite was scaled back ahead of this evening's release of the minutes of the latest Federal Reserve policy meeting. The FTSE 100 was trading as low as 6,400 today in London today; the last time it closed below this level was on July 5th when

21 Aug 13 11:33

UPDATE 2-Strong doxycycline sales boost Hikma revenue forecast

* Sees 2013 revenue growth of 20 pct * First-half profit up 93 pct * First-half revenue up 20 pct By Abhirup Roy Aug 21 (Reuters) - Hikma Pharmaceuticals raised its full-year revenue forecast for the third time in four months, riding on strong sales of generic antibiotic d

21 Aug 13 11:16

London open: FTSE 100 slips as investors await Fed minutes

The FTSE 100 fell into the red on Wednesday morning, hitting a fresh six-week low as investors nervously awaited the minutes of the latest Federal Reserve meeting. The index dropped 0.5% to around the 6,420 mark early on. The last time the London benchmark closed lower was on July 5th when it finis

21 Aug 13 08:29

UPDATE 1-Hikma raises 2013 revenue outlook on high doxycycline sales

Aug 21 (Reuters) - Hikma Pharmaceuticals raised it full-year revenue forecast for the third time in four months this year riding on the back of strong sales of its generic antibiotic doxycycline. The company, which makes and sells branded and generic drugs, said it expected total revenue to

21 Aug 13 08:10

London pre-open: Stocks expected to fall ahead of FOMC minutes

Markets are expected to open lower on Wednesday morning as traders nervously await the minutes of the latest Federal Reserve meeting.   City sources predict the FTSE 100 will open down 12 points after hitting a six-week low of 6,453.46 yesterday. Market sentiment has been a little fragile ahead of

21 Aug 13 07:26

Hikma Pharmaceuticals raises full year guidance

Hikma Pharmaceuticals said it had made a strong start to the first half of its financial year, with all of its businesses performing well, as it raised its guidance to around 20 per cent revenue growth for the year. The multinational pharmaceutical firm said revenue increased by 19.9% to $638.3m in

21 Aug 13 07:08

Hikma raises full-year revenue outlook on high doxycycline sales

Aug 21 (Reuters) - Hikma Pharmaceuticals said it expected full-year revenue to rise 20 percent as strong sales of its generic antibiotic doxycycline in the United States continue and reported a 93 percent jump in first-half profit. The company, which makes and sells branded and generic drug

21 Aug 13 06:30

Friday broker round-up UPDATE

Aquarius Platinum: Deutsche Bank lowers target price from 63p to 60p keeping a buy recommendation. Ashmore Group: HSBC ups target price from 400p to 435p, while keeping overweight rating. ASOS: UBS raises target price from 4600p to 6000p staying with its buy recommendation. Aviva: Bank of America

9 Aug 13 07:29

MARKET EYE-Sun Pharma gains on brighter outlook for key drug

* Sun Pharmaceutical Industries Ltd rises 1.1 percent to near a record high and a second day of gains, after a competitor raised revenue guidance citing strong sale of a generic antibiotic also sold by Sun Pharma. * Hikma Pharmaceuticals Plc on Monday raised its full-year revenue forecast for the

10 Jul 13 07:18

London close: Economists wax optimistic on UK

Stocks registered a solid gain on Monday on the back of an advance in the banking sector. That came on the heels of what some economists termed a solid jobs report last Friday Stateside and upwards revisions to growth forecasts for the UK. Leading gains were shares of Royal Bank of Scotland, as Ch

8 Jul 13 17:08

FTSE 250 movers: Hikma, Bovis, Betfair, Balfour Beatty

Pharmaceutical group Hikma Pharmaceuticals topped the leaderboard after saying it expects revenue to grow by 17 per cent in 2013 compared to its previous guidance of 13 per cent. Bovis Homes Group gained after announcing its reservations in the first half were ahead of its expectations amid signs o

8 Jul 13 13:35

UPDATE 1-Hikma raises full-year revenue forecast again

* Expects full-year total revenue to rise 17 percent * Sees full-year generics business revenue of $200 mln * Shares up as much as 9 pct (Adds analysts' comments, details; updates share movement) July 8 (Reuters) - Hikma Pharmaceuticals Plc raised its full-year revenue forecas

8 Jul 13 10:29

Monday broker round-up UPDATE

Anglo American: Exane reduces target price from 1700p to 1400p and reiterates its underperform rating. Anite Group: Investec raises target price from 135p to 155p and upgrades from hold to buy. Ashmore Group: RBC Capital Markets takes target price from 440p to 375p and keeps its neutral rating. B

8 Jul 13 08:48

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.